chartexchange

CTMX
CytomX Therapeutics, Inc.
stockNASDAQ

At CloseNov 18, 2026 3:59:57 PM EST
1.88USD-2.835%(-0.06)4,386,510
Pre-marketNov 18, 2026 9:29:30 AM EST
2.02USD+4.124%(+0.08)
After-hoursNov 18, 2026 4:34:30 PM EST
1.90USD+0.796%(+0.02)
Loading…
Loading…
410.94M
Healthcare
Biotechnology
CEO
Sean McCarthy
HQ
South San Francisco, CA, USA
Previous Close
$1.94
Beta
1.57
52-Week High
$8.21 2026-03-16
52-Week Low
$1.87 2026-11-18
SMA 50
$2.46
SMA 200
$3.65
Avg. Vol 10D
5.62M
Avg. Vol 30D
4.69M
Avg. Vol 90D
3.79M
Relative Vol
0.94
218.00M
176.77M
45,246,966
0.2800%
9,400,000
Mar 16, 2027 (117d)
CTMX Profile

cytomx is an oncology-focused biopharmaceutical company pioneering a novel class of investigational antibody therapeutics based on its probody technology platform. the company uses the platform to create development-stage proprietary cancer immunotherapies against clinically-validated targets, as well as to develop first-in-class investigational cancer therapeutics against novel targets. cytomx believes that its probody platform has the potential to improve the combined efficacy and safety profile of monoclonal antibody modalities, including cancer immunotherapies, antibody drug conjugates and t-cell-recruiting bispecific antibodies. probody therapeutics are designed to take advantage of unique conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues. investigational probody therapeutics are being developed that address clinically-validated cancer targets in immuno-oncology, such as pd-l1 against which o

CTMX Performance
PeriodPriceDateChangeBeta
1W2.042026-11-12-7.60%0.691
1M2.342026-10-19-19.44%1.131
3M3.572026-08-19-47.20%1.410
6M3.642026-05-19-48.21%1.227
1Y3.632025-11-19-48.07%1.574
2Y0.892024-11-19+111.16%—
5Y7.342021-11-19-74.32%1.365
CTMX Stock Summary

CytomX Therapeutics, Inc. (NASDAQ:CTMX) stock price today is $1.89, and today's volume is 4,386,510. CTMX is down 2.835% today. The 30 day average volume is 4.69M. CTMX market cap is $410.94M with 218.00M shares outstanding.